tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Peter Verdult, 11 are a BUY (52.38%), 8 are a HOLD (38.1%), 2 are a SELL (9.52%).
Analyst Peter Verdult works at CITI with a stock forecast success ratio of 20% fulfilled within 33.6 days on average.
Peter Verdult’s has documented 41 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on SNY, Sanofi ADR at 31-Oct-2023.
Analyst best performing recommendations are on NVO (NOVO NORDISK A/S).
The best stock recommendation documented was for NVO (NOVO NORDISK A/S) at 3/2/2022. The price target of $59.68 was fulfilled within 36 days with a profit of $8.35 (16.27%) receiving and performance score of 4.52.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
31
$-0.86 (-2.70%)
41
14 days ago
5/9 (55.56%)
$-1.48 (-4.56%)
14
Hold
38
$6.14 (19.27%)
37
1 months 8 days ago
11/14 (78.57%)
$3.54 (10.27%)
22
Hold
44.45
$12.59 (39.52%)
73.23
7 months 22 days ago
0/2 (0%)
$7.09 (18.98%)
Hold
38
$6.14 (19.27%)
41
8 months 8 days ago
11/13 (84.62%)
$-2.43 (-6.01%)
23
40
$8.14 (25.55%)
42
8 months 11 days ago
10/22 (45.45%)
$-2.36 (-5.57%)
73
Which stock is Peter Verdult is most bullish on?
What Year was the first public recommendation made by Peter Verdult?
